A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male Participants
NCT03864601
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
14C-JNJ-56136379
Sponsor
Janssen Research & Development, LLC